Allergy and Congestion tablets recalled due to failed dissolution specifications
Dr. Reddy's Laboratories is recalling Allergy and Congestion (Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg) Extended-Release Tablets because they failed to meet dissolution specifications. Approximately 4,896 cartons distributed nationwide are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard is a manufacturing/specification defect (failed dissolution) rather than contamination or a high-risk condition. Per the rubric, Class III recalls are typically scored 1 or 2; the dissolution failure represents a quality control issue that warrants a Moderate rating.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Allergy and Congestion Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP (20 tablets per carton, NDC 11822-7388-5) because the product failed dissolution specifications. The affected product is Lot #AC2103329E with an expiration date of January 2023.
Approximately 4,896 cartons were distributed nationwide by Rite Aid. The tablets are an over-the-counter combination medication used to treat allergy and congestion symptoms.
Consumers who have this product should stop using it. If you have questions or concerns, contact Dr. Reddy's Laboratories or your healthcare provider.
The recalled product
- Product
- ALLERGY AND CONGESTION (FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI)
- Brand
- ALLERGY AND CONGESTION
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- dissolution-failure
- quality-control-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AC2103329E
- Exp 1/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27